MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.
Oliviero B, Varchetta S, Mele D, Pessino G, Maiello R, Falleni M, Tosi D, Donadon M, Soldani C, Franceschini B, Torzilli G, Piccolo G, Barabino M, Opocher E, Maestri M, Bernuzzi S, Wucherpfennig KW, Mondelli MU, Mantovani S.
Oliviero B, et al. Among authors: tosi d.
Oncoimmunology. 2022 Feb 21;11(1):2035919. doi: 10.1080/2162402X.2022.2035919. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35223192
Free PMC article.